|
|
| Research article summary (published 30 Aug 1997): |
Is long-term continuous therapy for recurrent herpes simplex safe?
Full Abstract
No abstract is currently available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.
Author information
Author/s: Wolf, R (R); Ruocco, V (V); Ruocco, E (E);
Journal and publication information
Publication Type: Comment; Letter
Journal: Journal of the American Academy of Dermatology (J Am Acad Dermatol), published in UNITED STATES. (Language: eng)
Reference: 1997-Sep; vol 37 (issue 3 Pt 1) : pp 508-10
Dates: Created 1997/10/17; Completed 1997/10/17; Revised 2004/11/17;
PMID: 9308577, status: MEDLINE (last retrieved date: 2/18/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
Comments and Corrections
CommentOn: J Am Acad Dermatol. 1996 Oct;35(4):503-20; quiz 521-2. (PMID: 8859276)
CommentOn: J Am Acad Dermatol. 1996 Oct;35(4):601-5. (PMID: 8859290)
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Antiviral Agents (0) ; Acyclovir (59277-89-3)Related articles
These are the most related articles currently in our database:
- Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections.
29 Jun 1992 - Cutaneous herpes simplex virus infections.
29 Apr 1991 - (+-)-(1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)-cyclobutyl] guanine [(+-)-BHCG or SQ 33,054]: a potent and selective inhibitor of herpesviruses.
30 Dec 1989 - Antiherpes effects and pharmacokinetic properties of 9-(4-hydroxybutyl) guanine and the (R) and (S) enantiomers of 9-(3,4-dihydroxybutyl)guanine.
29 Apr 1985 - [An effective treatment for a severe disease: herpetic encephalitis]
30 Dec 1985 - Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
30 May 1988 - Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches.
30 Dec 1986 - Update on antiviral agents.
30 Mar 1985 - Comparison of antiviral efficacies of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (brovavir) and acyclovir against herpes simplex virus type 1 infections in mice.
30 Jul 1990 - Enhanced efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine in combination with gamma interferon against herpes simplex virus type 2 in mice.
30 May 1985
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.